Today : 2026³â 06¿ù 30ÀÏ (È­¿äÀÏ) ·Î±×ÀΠ     ȸ¿ø°¡ÀÔ
Ȩ      33333               22222               Áß°í ÆÄ¶ó¼Ö ÆÇ¸Å              

  È¨     »ç¿ªºñÁ¯     Á¶Á÷  

Ȩ
  glory


  ºü¸¥°Ë»ö

½Å¹® ÀâÁö

»ýȰÁ¤º¸

Ȩ

33333
2009-06-10 17:45:46




µ¶ÀÚ ÇѸ¶µð
PLrKiaemMBwaWuvJab
Florentino russel9j@aol.com
PLrKiaemMBwaWuvJab
Archie gaylek54@lycos.com
PLrKiaemMBwaWuvJab
Kerry leigh1a@lycos.com
asynqgXiZHRWfPjpcF
Thanh johnathon2w@gmail.com
asynqgXiZHRWfPjpcF
Carrol dylan8q@gmail.com
asynqgXiZHRWfPjpcF
Eldon stanley2f@aol.com
asynqgXiZHRWfPjpcF
Rudolph germanvbq@aol.com
asynqgXiZHRWfPjpcF
Colin thomasnga@aol.com
asynqgXiZHRWfPjpcF
Paris quintin3t@aol.com
asynqgXiZHRWfPjpcF
An accountancy practice nonudeville.com For women who received estrogen alone, the findings were less certain. HRT in this group was associated with an increased risk for stroke and venous thrombosis, and a lowered risk for hip and total fractures. After discontinuation of therapy most of the effects were no longer evident. The investigators were surprised by and at a loss to explain a small nonsignificant drop in breast cancer. Following discontinuation of HRT this decrease achieved statistical significance. Women under the age of 60 in this group also had small but signifcant reductions in all-cause mortality and myocardial infarction.
Moses brianovt@gmail.com
[1] [2] [3] [4] [5] [6]



ÇÁ¸°Æ®Çϱ⠱â»ç¸ÞÀϺ¸³»±â


ÀÌÀüÀ¸·Î
°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù.